scholarly journals Clonazepam-induced lichenoid drug eruption: a case report

2021 ◽  
Vol 21 (1) ◽  
Author(s):  
Hee Won Yang ◽  
Jong Bin Bae ◽  
Jung-Im Na ◽  
Ki Woong Kim

Abstract Background Lichenoid drug eruption is rare and can mimic idiopathic lichen planus and other dermatoses. Clonazepam, a commonly used drug for the treatment of anxiety-related disorders and seizures, is known to be an unlikely cause of cutaneous adverse effects. Only one case report of LDE due to clonazepam has been reported. Case presentation A 81-year-old male patient with Alzheimer’s disease developed a lichenoid eruption after taking clonazepam. He developed a violaceous scaly patch on his lower extremities, from both buttocks to the feet. The cutaneous eruption resolved 2 months after cessation of clonazepam and with initiation of corticosteroid therapy. Conclusion A skin eruption that develops after clonazepam administration can be a lichenoid drug eruption, which is less likely to resolve spontaneously and requires discontinuation of clonazepam administration.

2021 ◽  
Vol 37 (1) ◽  
Author(s):  
Shreya Agarwal ◽  
Nimish Gupta

Abstract Background Leech infestation in the nose or nasopharyngeal region is a rare occurrence. The most common known cause is drinking water from natural water sources like ponds and rivers. Its hidden location of attachment in the nasopharynx and its uncommon occurrence make it easy to miss during diagnosis. Case presentation We present a case of a 61-year-old male patient with recurrent unilateral epistaxis without any apparent cause. He was diagnosed with leech infestation in the nasopharynx on endoscopic examination. This article reports the management of nasopharyngeal leech infestation and safety measures for this animate foreign body retrieval. Conclusion A vigilant approach, thorough history, and examination are a must. Though leeches are simple to remove most of the time, certain necessary precaution should be kept in mind for better management and prevention of further complications.


2021 ◽  
Vol 22 (1) ◽  
Author(s):  
Kelsi M. Morgan ◽  
Peace D. Imani

Abstract Background This is a case report of an asymptomatic SARS-CoV-2 infection associated with new-onset nephrotic syndrome in a pediatric patient. This is the third case of new-onset nephrotic syndrome in children associated with SARS-CoV-2 infection, but is the first case report describing a new-onset nephrotic syndrome presentation in a patient who had asymptomatic COVID-19 infection. Case presentation This is a case of a previously healthy 5 year old female who presented with new-onset nephrotic syndrome in the setting of an asymptomatic COVID-19 infection. She presented with progressive edema, and laboratory findings were significant for proteinuria and hypercholesterolemia. She was treated with albumin, diuretics, and corticosteroid therapy, and achieved clinical remission of her nephrotic syndrome within 3 weeks of treatment. Though she was at risk of hypercoagulability due to her COVID-19 infection and nephrotic syndrome, she was not treated with anticoagulation, and did not develop any thrombotic events. Conclusions Our case report indicates that SARS-CoV-2 infection could be a trigger for nephrotic syndrome, even in the absence of overt COVID-19 symptoms.


2019 ◽  
Vol 30 (5) ◽  
pp. NP15-NP17 ◽  
Author(s):  
Aleksandra Petrovic ◽  
Georgios Kymionis

Background: To describe the successful management of a massive iridoschisis after penetrating keratoplasty for keratoconus, using the nd:YAG punctures. Case presentation: A 73-year-old male patient has undergone four penetrating keratoplasties for keratoconus. Nine months after the last surgery, patient presented with massive iridoschisis involving the visual axis. Patient was successfully treated with nd:YAG laser iridopunctures. Conclusion: Massive iridoschisis could be a potential complication of keratoconus, especially after penetrating keratoplasty. This condition can be potentially treated with nd:YAG iridopunctures.


Author(s):  
Shailendra Vikram Jitendra Singh ◽  
Romita Bachaspatimayum ◽  
Subhalakshmi Devi Akham ◽  
Rita Devi Sanjenbam

<p class="abstract">Ganglions are tense, smooth, fluctuant, cystic transilluminant swellings commonly <span lang="EN-IN">found on the dorsum of the wrist, at the scapholunate articulation. Treatment modalities include aspiration, intralesional corticosteroids, surgical excision, etc. Hypopigmentation is one of the adverse effects associated with intralesional steroid therapy</span>.  <span lang="EN-IN">Here, we report </span><span lang="EN-IN">a 21 years old male patient who came with an asymptomatic whitish patch on the left wrist after receiving triaminolone 40 mg injection at the same site for a ganglion.</span><span lang="EN-IN">Case is being reported so as to create awareness of this benign condition amongst the treating physicians or surgeons.</span></p>


Author(s):  
Chiravila Omanakuttan Pillai Sambhu ◽  
Changuli Krishna Bhat Prathibha ◽  
Kesavan Parameswaran Namboothiri ◽  
Puthanmadom Venkataramana Sharma Anandaraman

Abstract Background Plaque Psoriasis is very embarrassing condition of skin as it produces itchy rashes and scaly lesions which may not respond well to the treatment. It can be correlated with Kitibhakushta which is one among the 18 types of Kushta (skin diseases). Several corticosteroids for skin applications are used now a day’s which gives only temporary relief. Case presentation A 36 years old moderate built male patient complains of blackish skin rashes with itching, pain and scaling all over the body for three months. Based on the symptoms, Dosha (Biological humors) involved were assessed as Kapha (binding factors) and Vata (vital force of life) and suggestive of Kitibhakushta. Diagnosis of the Plaque psoriasis was further confirmed by biopsy. Classical Kushta treatment was adopted here. As Poorvakarma (pre-operative procedures), Rukshana (Dehydrating therapy) was done and then Snehapana (intake of medicated ghee) was administered. Then classical Vamana (emetic therapy) and Virechana (purgative therapy) were performed. This took almost one month. After Samsarjana (special diet) patient was administered Manibhadragula as Shodhana Rasayana for a period of one month. Results At the end of Manibhadragula intake, remarkable changes were observed in all the symptoms. There were significant changes seen in PASI, DLQI and photographs taken before and after treatment. Conclusions Here the special mode of administration of Manibhadragula as mentioned in Ashtanga Hridaya helps for Shodhana and the Shodhana itself has Rasayana action. Drugs also have Rasayana property. This made the authors to propose a new concept called Shodhana Rasayana. Classical treatment by considering the condition of Roga (disease) and Rogi (patient) helps for management of Kushta.


2020 ◽  
pp. 1-2
Author(s):  
S. Arun Karthikeyan ◽  
N. Vignesh ◽  
M. Suganya ◽  
K. Manoharan

The follicular variant of lichen planus is also known as lichen planopilaris. it is an inflammatory, primary cicatricial alopecia which accounts for 30-40% of scarring alopecia. It usually occurs between 30 to 70 years of age group with a female predominance of varying ratio ranging between 1.8:1 and 9:1. LPP is usually an insidious process evolving over several years. It usually presents as irregular patchy hair loss with loss of follicular ostia and perifollicular erythema and perifollicular scales are typically present at the periphery of active lesions. So, hereby reporting this case for its rarity in occurrence in male patient.


Author(s):  
E. VANBELLEGHEM ◽  
J. WERBROUCK ◽  
S. VERSTRAETE ◽  
L. LIBBRECHT ◽  
F. D'HEYGERE

Persistent skin eruption in a 52-year-old man losing weight This case report describes a 52-year-old male patient with important weight loss, fatigue, diarrhea and a skin eruption since 1 year. An olmesartan-induced enteropathy and skin vasculitis were diagnosed. There was a total resolution of the symptoms after the interruption of olmesartan. Although sprue-like enteropathy and cutaneous vasculitis are very rare, clinicians should be aware of those potential adverse events, even years after the initiation of an angiotensin II receptor blocker.


1989 ◽  
Vol 51 (5) ◽  
pp. 958-962
Author(s):  
Minoru OHTSUYAMA ◽  
Tomohiro MARUYAMA ◽  
Shozo TAKAHASHI ◽  
Masaaki MOROHASHI

Sign in / Sign up

Export Citation Format

Share Document